Skip to main content
logo
Strides Pharma Science Limited (NSE:STAR)
India flag India · Delayed Price · Currency is INR
908.15
-12.10 (-1.31%)
Jul 25, 2025, 3:29 PM IST

Strides Pharma Science Revenue

In the fiscal year ending March 31, 2025, Strides Pharma Science had annual revenue of 45.65B INR with 17.36% growth. Strides Pharma Science had revenue of 11.90B in the quarter ending March 31, 2025, with 28.96% growth.

Revenue
45.65B
Revenue Growth
+17.36%
P/S Ratio
1.83
Revenue / Employee
13.83M
Employees
3,301
Market Cap
83.70B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202545.65B6.75B17.36%
Mar 31, 202438.90B2.02B5.47%
Mar 31, 202336.88B6.18B20.13%
Mar 31, 202230.70B-2.46B-7.41%
Mar 31, 202133.16B5.64B20.49%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries525.78B
Divi's Laboratories93.60B
Cipla272.67B
Mankind Pharma122.07B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Aurobindo Pharma317.24B
Fortis Healthcare77.86B
Revenue Rankings

Strides Pharma Science News

More News